Duncan W.

Duncan W. has a wealth of experience in the biopharmaceutical industry. Duncan is currently serving as the Chief Development Officer (CDO) at OnKure Therapeutics since July 2021. Prior to this role, they were the Head of Oncology at Kymera Therapeutics from January 2019 to July 2021. Duncan has also held leadership positions at FORMA Therapeutics, Inc. as the VP Preclinical and Early Development from May 2014 to December 2018, at Array BioPharma as the Head Translational Medicine, Oncology from July 2007 to May 2014, and at Sunesis Pharmaceuticals as the VP Biology from September 2002 to October 2006. Before transitioning into the industry, Duncan worked as a Sr Research Investigator in Cancer Biology at Glaxo Wellcome from 1993 to 1998. Duncan also served as a Howard Hughes Postdoctoral Fellow at the University of Colorado Health Sciences Center from 1990 to 1993.

Duncan W. obtained a PhD in Biochemistry and Molecular Biology from Washington University in St. Louis, where they studied from 1985 to 1990.